Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Pediatrics

University of Tennessee

Memphis

TN 38163

USA

Name/email consistency: high

Department of Pediatrics, University of Tennessee, Memphis, TN 38163, USA. 2007
University of Tennessee Health Science Center, College of Medicine, 956 Court Avenue, Room G326, USA. 2006
Department of Pediatrics, University of Tennessee, and Research Service, Veterans Affairs Medical Center, USA. 2004
University of Tennessee, Memphis 38163, USA. 2004

An altered peptide ligand of type II collagen suppresses autoimmune arthritis. Myers, L.K., Tang, B., Rosioniec, E.F., Stuart, J.M., Kang, A.H. Crit. Rev. Immunol. (2007) [Pubmed]
The isozyme-specific effects of cyclooxygenase-deficiency on bone in mice. Myers, L.K., Bhattacharya, S.D., Herring, P.A., Xing, Z., Goorha, S., Smith, R.A., Bhattacharya, S.K., Carbone, L., Faccio, R., Kang, A.H., Ballou, L.R. Bone (2006) [Pubmed]
Relevance of posttranslational modifications for the arthritogenicity of type II collagen. Myers, L.K., Myllyharju, J., Nokelainen, M., Brand, D.D., Cremer, M.A., Stuart, J.M., Bodo, M., Kivirikko, K.I., Kang, A.H. J. Immunol. (2004) [Pubmed]
An analog peptide that suppresses collagen-induced arthritis. Myers, L.K., Sakurai, Y., Rosloniec, E.F., Stuart, J.M., Kang, A.H. Am. J. Med. Sci. (2004) [Pubmed]
Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis. Myers, L.K., Tang, B., Brand, D.D., Rosloniec, E.F., Stuart, J.M., Kang, A.H. Arthritis Rheum. (2004) [Pubmed]